Cue Biopharma, Inc. (CUE): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-30, first reflected in a filing dated 2026-05-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2022-12-31, 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

96.62M
As of 2025-12-31
5.23M
As of 2026-06-30
2017-12-31: 19.46M2018-12-31: 20.70M2019-12-31: 26.56M2020-12-31: 30.35M2021-12-31: 32.20M2022-12-31: 47.22M2023-12-31: 47.22M2024-12-31: 61.82M2025-12-31: 96.62M96.62M
2017-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3196.62M+56.3%2026-03-16, Balance as of period end
2024-12-3161.82M+30.9%2026-03-16, Balance as of period end
2023-12-3147.22Mn/c2025-03-31, Balance as of period end
2022-12-3147.22Mn/c2024-03-28, Balance as of period end
2021-12-3132.20M+6.1%2023-03-21, Balance as of period end
2020-12-3130.35M+14.3%2022-03-16, Balance as of period end
2019-12-3126.56M+28.3%2021-03-09, Balance as of period end
2018-12-3120.70M+6.4%2020-03-12, Balance as of period end
2017-12-3119.46Mn/a2019-03-14, Balance as of period end